CIK1 Antibody

Shipped with Ice Packs
In Stock

Description

Cik1 Protein in Saccharomyces cerevisiae

Cik1 is a regulatory partner of the kinesin Kar3 in budding yeast, critical for spindle dynamics and chromosome segregation. Key findings include:

Functional Isoforms and Regulation

  • Two Cik1 isoforms exist:

    • Long isoform (Cik1L): Contains an N-terminal APC/C-targeting domain, degraded via APC/C-Cdh1 during mitosis .

    • Short isoform (Cik1S): Expressed during mating, lacks degradation signals, enabling stable nuclear fusion .

  • Cik1L degradation ensures mitotic exit, while Cik1S persistence facilitates karyogamy .

Mechanistic Roles

  • Cik1/Kar3 stabilizes kinetochore-microtubule attachments, preventing syntelic (both sister chromatids to same pole) errors .

  • Disruption of Cik1-Kar3 interaction (e.g., via Cik1-CC overexpression) mimics cik1Δ phenotypes: chromosome missegregation and temperature sensitivity .

Therapeutic CIK Cells and Antibody Combinations

While no direct "CIK1 antibody" exists in clinical use, cytokine-induced killer (CIK) cells combined with immune checkpoint inhibitors (e.g., PD-1 antibodies) show therapeutic promise in oncology:

Key Clinical Trials

Trial DesignPatient CohortOutcomes (Combination vs. PD-1 Alone)Source
NSCLC (Phase IB)34 patients, stage IIIB-IVORR: 82.4% vs. 9.1%; DCR: 100% vs. 45.5%
Renal Cell Carcinoma29 patientsImproved PFS (19.3 months median)
Advanced NSCLC (Retrospective)18 patientsCD3+CD56+ T cells ↑; MDSC levels ↓

Mechanistic Synergy

  • CIK cells enhance CD3+CD56+ effector T cells, counteracting myeloid-derived suppressor cells (MDSCs) .

  • PD-1 antibodies (e.g., pembrolizumab) block inhibitory signals, amplifying CIK cell cytotoxicity .

  • Preclinical data suggest CIK cells reverse PD-1 resistance in PD-L1-low tumors .

Antibody Development Challenges

  • Chimeric/humanized designs reduce immunogenicity for therapeutic use .

  • Target validation requires epitope mapping (e.g., Cik1’s coiled-coil domain for functional studies) .

Critical Distinctions and Future Directions

  • CIK1 ≠ CIK cells: Cik1 is a yeast protein; CIK cells are ex vivo-expressed lymphocytes.

  • Research gaps: No antibodies against Cik1 are reported in public databases (e.g., Human Protein Atlas ).

Future priorities:

  • Develop isoform-specific Cik1 antibodies to study mitotic vs. mating roles.

  • Optimize CIK cell/antibody combinations via biomarkers (e.g., CD4+ T cell subsets ).

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
CIK1 antibody; YMR198W antibody; YM9646.11Spindle pole body-associated protein CIK1 antibody; Chromosome instability and karyogamy protein 1 antibody
Target Names
CIK1
Uniprot No.

Target Background

Function
CIK1 is a developmentally regulated protein that plays a crucial role in microtubule functions. It directs KAR3 to the cytoplasmic microtubules during mating, which is essential for KAR3's activity during prophase of meiosis I. CIK1 is also vital for interhomolog recombination, the synapsis of homologous chromosomes, and the establishment of a meiosis I spindle.
Gene References Into Functions
  1. Cryoelectron microscopy has been used to generate a 3-D structure of the Kar3Cik1 complex bound to microtubules in various nucleotide states. PMID: 24099757
  2. Research has shown that Cik1 facilitates the association of Kar3 with kinetochores, and this association occurs only before chromosome bipolar attachment. PMID: 22319456
  3. A model has been proposed where Kar3Cik1 interacts with the microtubule lattice through a cycle of Cik1 microtubule collision followed by Kar3 microtubule binding. This cycle is regulated by the Kar3 nucleotide state and intramolecular strain, with communication between Kar3 and Cik1 occurring at the head-head interface. PMID: 21680740
  4. Cik1 targets the minus-end kinesin depolymerase Kar3 to microtubule plus ends. PMID: 16085496
  5. Structural modifications in Kar3 upon dimerization with Cik1 alter the motor velocity and likely regulate Kar3 activity in vivo. PMID: 16107877

Show More

Hide All

Database Links

KEGG: sce:YMR198W

STRING: 4932.YMR198W

Subcellular Location
Nucleus. Cytoplasm, cytoskeleton, microtubule organizing center, spindle pole body.

Q&A

What is CIK1 and what is its role in cellular processes?

CIK1 (Casein Kinase Interacting protein 1) is a 594 amino acid protein that functions as a developmentally regulated spindle pole body-associated protein . It forms a heterodimeric motor complex with Kar3, which plays crucial roles in chromosome organization during cell division in yeast. The Cik1/Kar3 complex facilitates chromosome bipolar attachment, which is essential for proper chromosome segregation during mitosis . This complex has been particularly well-studied in budding yeast, where it contributes to the establishment of tension on chromosomes through its interaction with kinetochores. Disruption of CIK1 function results in significant defects in chromosome attachment and subsequent cell cycle progression. Research indicates that CIK1 mediates the interaction between Kar3 and kinetochore components, particularly the MIND complex protein Nnf1, thus linking microtubule motor function to chromosome movement .

What applications are CIK1 antibodies commonly used for in research?

CIK1 antibodies are valuable tools in multiple research applications, particularly for studying protein-protein interactions and cellular localization. Based on related antibody research, common applications include Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (IF), and co-Immunoprecipitation (co-IP) . In co-IP experiments, CIK1 antibodies have been instrumental in demonstrating interactions between CIK1 and partner proteins like Kar3, as well as identifying novel binding partners . For analyzing CIK1's association with centromeric regions, Chromatin Immunoprecipitation (ChIP) has proven particularly effective . When selecting a CIK1 antibody, researchers should consider factors such as host species (commonly rabbit polyclonal antibodies), clonality (polyclonal antibodies offer broader epitope recognition), and specific reactivity to the organism being studied . The selection of conjugated or unconjugated antibodies depends on the specific application, with unconjugated antibodies offering greater flexibility across different detection methods.

How do CIK1 antibodies differ from other related kinase antibodies?

While the search results don't provide direct comparisons between CIK1 antibodies and other kinase antibodies, we can infer some distinctions based on the information about Casein Kinase 1 epsilon (CSNK1E) antibodies . Unlike antibodies targeting catalytic kinase domains that may cross-react with multiple kinase family members, CIK1 antibodies target a non-catalytic protein that functions as a partner to Kar3 motor protein, potentially offering higher specificity . When studying kinase-associated proteins like CIK1, researchers should be particularly careful about epitope selection, as different functional domains (such as the coiled-coil domain) may be involved in specific protein-protein interactions . While kinase antibodies often target phosphorylation sites or catalytic domains, CIK1 antibodies may be designed to recognize structural motifs that mediate protein-protein interactions, such as the coiled-coil region that enables CIK1 to associate with Kar3 .

What are the optimal conditions for CIK1 antibody use in co-immunoprecipitation studies?

For effective co-immunoprecipitation studies involving CIK1, researchers should consider several methodological factors. Based on successful experiments documented in the literature, cell extracts should be prepared from mid-log phase cultures to ensure active protein expression and complex formation . When investigating CIK1-Kar3 interactions, antibodies targeting epitope tags such as HA or myc have proven effective, with anti-HA antibodies successfully pulling down Kar3-HA and co-precipitating interacting proteins . The experimental approach described in the research involved:

  • Growing tagged strains (e.g., KAR3-3HA NNF1-13myc) to mid-log phase

  • Preparing cell extracts under conditions that preserve protein-protein interactions

  • Performing immunoprecipitation with either anti-HA or anti-myc antibodies

  • Analyzing precipitates via Western blotting to detect interacting partners

This reciprocal co-IP approach (where each protein can pull down the other) provides stronger evidence of genuine interaction. When studying the effect of CIK1 disruption, comparing wild-type, cik1Δ, and vik1Δ strains provides valuable insights into the specificity of interactions . Critical controls should include untagged strains and empty vector controls when overexpression studies are performed.

How can I effectively use CIK1 antibodies in chromatin immunoprecipitation (ChIP) assays?

Chromatin immunoprecipitation (ChIP) has been successfully employed to study CIK1's association with centromeric regions and its role in kinetochore function. Based on published methodologies, researchers should:

  • Synchronize cell populations (e.g., using G1 arrest and release) to examine cell cycle-specific associations

  • Cross-link proteins to DNA using formaldehyde (conditions not specified in the search results)

  • Immunoprecipitate with antibodies against tagged proteins (e.g., KAR3-13myc)

  • Perform PCR with primers specific for centromeric regions (e.g., CEN1, CEN3)

Quantification should involve normalizing the PCR yield (IP/input ratio) in experimental samples to that in wild-type cells. The research demonstrated that cik1Δ mutant cells show decreased Kar3-centromere interaction, with quantifiable differences in ChIP signal . Appropriate controls should include an untagged strain as a negative control and non-centromeric regions (e.g., ACT1) to demonstrate specificity of centromere association . Temperature-sensitive mutants (e.g., cdc13-1) can be used to arrest cells at specific cell cycle stages when examining cell cycle-dependent associations. This approach has successfully demonstrated that Ask1 centromere association is decreased in cik1Δ mutant cells, while Nnf1 association remains normal .

What cell synchronization methods work best when studying CIK1 function in chromosome dynamics?

Effective cell synchronization is crucial for studying CIK1's role in chromosome dynamics throughout the cell cycle. Based on research protocols, several approaches have proven successful:

  • G1 synchronization and release: Using alpha-factor arrest in budding yeast followed by release into specific conditions (e.g., galactose-containing medium to induce protein expression)

  • Temperature-sensitive mutant arrests: Utilizing cdc13-1 mutants, which arrest at preanaphase at high temperatures (32-34°C) due to DNA damage checkpoint activation, allowing the study of established bipolar attachments

  • HU-mediated arrest: Hydroxyurea treatment to inhibit DNA synthesis and study the role of CIK1/Kar3 in facilitating chromosome bipolar attachment

  • Cohesin defect-based approaches: Using temperature-sensitive mcd1-1 cohesin mutants at 37°C to abolish cohesion between sister chromatids and allow spindle elongation regardless of checkpoint activation

Each method offers specific advantages depending on the research question. For studying bipolar attachment establishment, the cdc13-1 arrest at 32°C combined with CEN4-GFP and TUB1-mCherry markers allows visualization of centromere positioning relative to the spindle . For examining sister chromatid segregation defects, the mcd1-1 approach at 37°C enables assessment of co-segregation patterns even in the presence of checkpoint activation . Researchers should select the synchronization method that best aligns with their specific experimental endpoints and the temporal aspects of CIK1 function they wish to investigate.

How does the Cik1/Kar3 motor complex contribute to chromosome attachment?

The Cik1/Kar3 motor complex plays a crucial role in establishing proper chromosome attachment during mitosis. According to detailed research findings, this complex specifically prevents syntelic attachment, where two sister kinetochores attach to the same spindle pole . The mechanism involves several key processes:

  • Kinetochore-microtubule interaction: Cik1 mediates the association of Kar3 with kinetochores through interaction with Nnf1, a component of the MIND kinetochore complex . This interaction was demonstrated through co-immunoprecipitation experiments showing that Kar3-HA can pull down Nnf1-myc, and this interaction is abolished in cik1Δ mutants .

  • Tension generation: After proper bipolar attachment, chromosomes congress to the spindle equator, resulting in tension between sister kinetochores. In cells lacking Cik1/Kar3 function, this tension generation is compromised . This was visualized using CEN4-GFP marked centromeres, where 51% of cells overexpressing CIK1-CC (which disrupts Cik1-Kar3 interaction) showed CEN4-GFP localized at one end of the spindle, compared to only 12% in control cells .

  • Prevention of syntelic attachment: Without functional Cik1/Kar3, sister chromatids frequently co-segregate to the same cell pole. This was quantitatively demonstrated in mcd1-1 cohesin mutants, where 31% of cells with disrupted Cik1/Kar3 function exhibited co-segregation of sister centromeres, compared to only 4% in control cells .

The research employed elegant genetic approaches, including overexpression of the coiled-coil domain of CIK1 (CIK1-CC) to competitively disrupt the Cik1-Kar3 interaction, mimicking the phenotype of cik1Δ and kar3Δ mutants . This technique allowed researchers to study chromosome behavior in the absence of functional Cik1/Kar3 complex even in genetic backgrounds where complete deletion would be lethal.

What evidence supports CIK1's role in mediating Kar3-kinetochore interactions?

Multiple lines of experimental evidence firmly establish CIK1's role in mediating the interaction between Kar3 and kinetochores:

  • Co-immunoprecipitation studies: Reciprocal co-IP experiments demonstrated that Kar3-HA interacts with Nnf1-myc (a kinetochore component) in vivo. This interaction was completely abolished in cik1Δ mutants but remained intact in vik1Δ mutants, indicating that Cik1, but not its alternative partner Vik1, is specifically required for Kar3-kinetochore interaction .

  • Chromatin immunoprecipitation (ChIP): ChIP assays revealed diminished association of Kar3 with centromeric DNA in cik1Δ cells compared to wild-type cells. Quantitative analysis showed a significant reduction in Kar3-centromere interaction in the absence of Cik1 .

  • Competitive disruption approaches: Overexpression of the coiled-coil domain of Cik1 (CIK1-CC) disrupted the interaction between Kar3-HA and Nnf1-myc, further supporting the model that Cik1 mediates this kinetochore interaction .

  • Differential effects on kinetochore components: While the centromere association of Ask1 (a kinetochore component) was decreased in cik1Δ mutant cells, the association of Nnf1 with centromeric DNA remained normal. This suggests that Cik1 specifically affects the recruitment of certain kinetochore components rather than disrupting the entire kinetochore structure .

Together, these findings establish a model where Cik1 serves as a critical mediator that links the Kar3 motor protein to kinetochores through interaction with specific kinetochore components like Nnf1.

What genetic interactions provide insights into the functional roles of CIK1?

Genetic interaction studies have revealed important insights into CIK1's functional roles, particularly in chromosome segregation and spindle checkpoint mechanisms:

  • Synthetic lethality with checkpoint mutants: Both cik1Δ and kar3Δ are synthetically lethal with spindle checkpoint mutants (bub1, mad1, mad2, and mad3) and tension checkpoint mutants (sgo1Δ and ipl1-321). This genetic interaction with tension checkpoint mutants suggests that the Cik1/Kar3 complex facilitates the establishment of chromosome bipolar attachment that generates tension on chromosomes .

  • Checkpoint dependency: Cells overexpressing CIK1-CC (which disrupts Cik1/Kar3 function) exhibit cell cycle delay and Pds1 stabilization. This delay is eliminated in spindle checkpoint mutant mad1Δ and tension checkpoint mutants sgo1Δ and ipl1-321, indicating that tension defects activate the checkpoint in cells lacking Cik1/Kar3 .

  • Genetic interactions with kinetochore components: Overexpression of CIK1-CC is lethal in ask1 mutants, suggesting functional interaction between the Cik1/Kar3 complex and this kinetochore component .

  • Partner-specific functions: While Kar3 can form a heterodimer with either Cik1 or Vik1, the Kar3-kinetochore interaction specifically depends on Cik1, not Vik1. This supports distinct functional roles for these alternative Kar3 partners .

These genetic interactions collectively support a model where CIK1 functions in ensuring proper chromosome attachment and tension generation, with its dysfunction activating spindle and tension checkpoints to prevent chromosome missegregation.

How can I overcome issues with non-specific binding when using CIK1 antibodies?

While the search results don't specifically address troubleshooting for CIK1 antibodies, we can derive recommendations based on standard immunological methods and the successful experimental approaches described:

  • Antibody selection: Choose antibodies with demonstrated specificity for your target species and application. For CIK1 research, polyclonal antibodies targeting specific domains may offer advantages for certain applications . Consider using affinity-purified antibodies, which typically show reduced non-specific binding .

  • Blocking optimization: When performing immunoprecipitation or Western blotting, optimize blocking conditions to reduce background. The successful co-IP experiments in the research suggest that standard blocking protocols were effective for detecting CIK1-Kar3 and Kar3-Nnf1 interactions .

  • Control experiments: Always include appropriate controls to distinguish specific from non-specific signals:

    • Untagged strains as negative controls for tagged protein detection

    • Isotype controls for primary antibodies

    • Knockout or knockdown samples where possible (e.g., cik1Δ strains)

  • Epitope tag strategies: Consider using epitope-tagged proteins (like the myc and HA tags used in the research) when possible, as antibodies against these tags often show high specificity and are well-characterized .

  • Cross-adsorption: For applications requiring extremely high specificity, consider using cross-adsorbed secondary antibodies to minimize cross-reactivity with related proteins.

The successful detection of specific CIK1 interactions in the research suggests that with proper optimization, issues with non-specific binding can be effectively managed in CIK1 research applications.

What are the best approaches for visualizing CIK1 localization in living cells?

For effective visualization of CIK1 localization in living cells, researchers should consider these methodological approaches based on successful strategies in related research:

  • Fluorescent protein tagging: The research successfully used GFP-marked centromeres (CEN4-GFP) and mCherry-labeled microtubules (TUB1-mCherry) to study chromosome positioning relative to the spindle . Similar approaches could be applied to visualize CIK1 by creating functional CIK1-GFP or CIK1-mCherry fusion proteins.

  • Conditional expression systems: When studying proteins whose disruption leads to severe phenotypes, galactose-inducible promoters (as used for CIK1-CC overexpression) allow controlled expression for time-course studies .

  • Cell synchronization: For cell cycle-dependent localization studies, synchronize cells using methods such as alpha-factor arrest (G1), hydroxyurea treatment (S-phase), or nocodazole treatment (mitosis) .

  • Co-localization studies: To determine CIK1's association with specific cellular structures, combine CIK1 fluorescent tagging with markers for structures of interest, such as the TUB1-mCherry spindle marker used in the research .

  • Temperature-sensitive mutant backgrounds: Using temperature-sensitive mutants like cdc13-1 can allow arrest at specific cell cycle stages to examine CIK1 localization at those points .

  • Live-cell imaging conditions: For yeast cells, consider using concanavalin A-coated slides to immobilize cells while maintaining viability for extended imaging sessions.

The successful visualization of centromere positioning relative to the spindle in the research provides a methodological framework that can be adapted for studying CIK1 localization in living cells.

How do recent findings about CIK1 impact our understanding of chromosome segregation disorders?

Recent findings on CIK1 function provide significant insights into chromosome segregation disorders, though the search results don't explicitly connect CIK1 to human disease. The discovery that loss of Cik1/Kar3 function results in syntelic attachment, where sister kinetochores incorrectly attach to the same spindle pole, has important implications . This attachment error can lead to chromosome missegregation, a hallmark of many disorders including cancer and developmental abnormalities. The research demonstrates that proper chromosome bipolar attachment depends on the Cik1/Kar3 complex, with 51% of cells lacking this function showing defective attachment compared to 12% in control cells .

Furthermore, the finding that Cik1 mediates the interaction between Kar3 and kinetochore components like Nnf1 highlights how specific protein-protein interactions ensure accurate chromosome segregation . Disruption of analogous interactions in humans could potentially contribute to aneuploidy and genomic instability. The research also revealed that cells with disrupted Cik1/Kar3 function exhibit delayed anaphase entry due to checkpoint activation, suggesting a mechanism by which cells attempt to prevent chromosome missegregation . Understanding these molecular mechanisms provides potential targets for therapeutic intervention in disorders characterized by chromosome segregation defects.

What are the most promising directions for future research on CIK1 function?

Based on current findings, several promising directions for future CIK1 research emerge:

  • Structural biology approaches: Determining the three-dimensional structure of the Cik1/Kar3 complex and its interaction with kinetochore components would provide mechanistic insights into how this complex prevents syntelic attachment. While the research identified the coiled-coil domain as important for Cik1-Kar3 interaction, detailed structural information remains limited .

  • Single-molecule studies: Investigating the motor properties of the Cik1/Kar3 complex at the single-molecule level could reveal how it contributes to kinetochore movement and tension generation. The search results suggest the complex influences chromosome positioning, but the biophysical mechanisms remain to be elucidated .

  • Interactome mapping: Comprehensive identification of CIK1-interacting proteins beyond Kar3 and Nnf1 could reveal additional roles in cellular processes. The research focused on specific interactions, but a broader interactome would provide a more complete functional picture .

  • Human orthologs and disease relevance: Identifying and characterizing human orthologs or functional analogs of CIK1 could connect this research to human health and disease. While the current research uses yeast models, similar mechanisms likely operate in human cells .

  • Checkpoint signaling mechanisms: Further investigation into how Cik1/Kar3 dysfunction activates tension and spindle checkpoints could reveal new aspects of checkpoint signaling. The research showed checkpoint dependency but did not fully explore the signaling mechanisms involved .

These research directions would build on the foundation established by current findings and potentially lead to new therapeutic strategies for chromosome segregation disorders.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.